Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 - Archive ouverte HAL Access content directly
Journal Articles Eurosurveillance Year : 2019

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Abstract

Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Dates and versions

hal-02355359 , version 1 (08-11-2019)

Identifiers

Cite

Esther Kissling, Angela Rose, Hanne-Dorthe Emborg, Alin Gherasim, Richard Pebody, et al.. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Eurosurveillance, 2019, 24 (8), pp.21. ⟨10.2807/1560-7917.ES.2019.24.1900121⟩. ⟨hal-02355359⟩
43 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More